Entity

Time filter

Source Type

Albany, NY, United States

Yang Z.,Discovery R and D AMRI | Fairfax D.J.,Discovery R and D AMRI | Maeng J.-H.,Discovery R and D AMRI | Masih L.,Discovery R and D AMRI | And 23 more authors.
Bioorganic and Medicinal Chemistry Letters | Year: 2010

A new class of 2-substituted benzoxazole carboxamides are presented as potent functional 5-HT3 receptor antagonists. The chemical series possesses nanomolar in vitro activity against human 5-HT3A receptors. A chemistry optimization program was conducted and identified 2-aminobenzoxazoles as orally active 5-HT3 receptor antagonists with good metabolic stability. These novel analogues possess drug-like characteristics and have potential utility for the treatment of diseases attributable to improper 5-HT3 receptor function, especially diarrhea predominant irritable bowel syndrome (IBS-D). © 2010 Elsevier Ltd. All rights reserved. Source

Discover hidden collaborations